GlobeNewsWire
23 Sept 2026, 00:46 UTC · 1h ago
Verdict
Headline takes no side. We score INNV −0.20 across three claims — slightly bearish.
−0.20slightly bearish
More negative than 68% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish · 3 new · 0 priced in
Selling stockholders affiliated with Apax Partners and Welsh, Carson, Anderson & Stowe have priced an offering of 10,000,000 shares of common stock at $9.25 per share.
Newpress release dated Sept 22, 2026
More negative than 86% of claims this week
Underwriters have a 30-day option to purchase up to an additional 1,500,000 shares from the selling stockholders.
New
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
So whatIf fully exercised, the total secondary sale would increase to 11.5 million shares, further expanding the available supply.
More negative than 70% of claims this week
InnovAge will not receive any proceeds from this offering but will bear the costs associated with the sale.
Newpress release dated Sept 22, 2026
More negative than 65% of claims this week
Which stocks this story touches
More negative than 68% of ticker scores this week
The company will bear the costs of a secondary offering where existing investment funds sell shares, potentially creating downward price pressure.
More positive than 47% of ticker scores this week
The company is acting as a lead book-running manager for the public offering, generating fee income.
More positive than 47% of ticker scores this week
The company is acting as a lead book-running manager for the public offering, generating fee income.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
More positive than 17% of relationship scores this week
[a_to_b] Barclays is acting as a lead book-running manager and underwriter for InnovAge's secondary offering.
More positive than 17% of relationship scores this week
[a_to_b] UBS Investment Bank is acting as a book-running manager for InnovAge's secondary offering.
More positive than 17% of relationship scores this week
[a_to_b] Wells Fargo is acting as a lead book-running manager and underwriter for InnovAge's secondary offering.
—
INNV hasn't traded since this ran. Last close $10.65 (Sep 22); the reaction starts at the next open.
INNV chart →